DrugsControl Media Services
DrugsControl.org

News Detail

Rs 72-lakh Cancer medicine for Rs 3 lakh, Patent ends (15-03-2024)

New Delhi, 15 March 2024: India’s Zydus Lifesciences on Wednesday announced its launch of a generic version of an anti-cancer medicine called olaparib that the company said would be available to patients at a fraction of the cost of the original innovator molecule.

......
View Details

Source : The Telegraph India
Cancer Medicine drugs Zydus anti-cancer

Related News